More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...

Gear, apparel, accessories and more to show off your purple pride.

PanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.

Join PanCAN on Jan. 30, at 11 a.m. PT / 2 p.m. ET, for an educational discussion about pancreatic cancer clinical trials and ...

El páncreas es una glándula que mide alrededor de seis pulgadas de largo y se ubica en el abdomen. Está rodeada por el estómago, el intestino delgado, el hígado, el bazo, y la vesícula biliar. Tiene ...

Caregivers are crucial in the pancreatic cancer patient’s journey. We have information and resources to guide you as you care for a loved one facing the disease.

Clinical trials are research studies that investigate new treatments, new combinations of treatments and new methods of diagnosis as well as surveillance, prevention, and supportive care. Clinical ...

Home Aprenda Sobre el Cáncer de Páncreas El Páncreas DIAGNÓSTICO Antígeno Carcinoembrionario (CEA, por sus siglas en inglés) La prueba del antígeno carcinoembrionario (CEA) es un análisis de sangre ...

Home Aprenda Sobre el Cáncer de Páncreas El Páncreas La Dieta y Nutrición para Personas con Cáncer de Páncreas Cambios Nutricionales Después de Una Cirugía Pancreática Los pacientes con cáncer de ...

On World Pancreatic Cancer Day, hundreds of patients, caregivers and loved ones tuned in for our special virtual event, “How Early Detection Can Change the Course for Pancreatic Cancer.” Our guests ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...